Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Aging Cell. 2021 May;20(5):e13347. doi: 10.1111/acel.13347. Epub 2021 Mar 21.
D620N mutation in the vacuolar protein sorting 35 ortholog (VPS35) gene causes late-onset, autosomal dominant familial Parkinson's disease (PD) and contributes to idiopathic PD. However, how D620N mutation leads to PD-related deficits in vivo remains unclear. In the present study, we thoroughly characterized the biochemical, pathological, and behavioral changes of a VPS35 D620N knockin (KI) mouse model with chronic aging. We reported that this VPS35 D620N KI model recapitulated a spectrum of cardinal features of PD at 14 months of age which included age-dependent progressive motor deficits, significant changes in the levels of dopamine (DA) and DA metabolites in the striatum, and robust neurodegeneration of the DA neurons in the SNpc and DA terminals in the striatum, accompanied by increased neuroinflammation, and accumulation and aggregation of α-synuclein in DA neurons. Mechanistically, D620N mutation induced mitochondrial fragmentation and dysfunction in aged mice likely through enhanced VPS35-DLP1 interaction and increased turnover of mitochondrial DLP1 complexes in vivo. Finally, the VPS35 D620N KI mice displayed greater susceptibility to MPTP-mediated degeneration of nigrostriatal pathway, indicating that VPS35 D620N mutation increased vulnerability of DA neurons to environmental toxins. Overall, this VPS35 D620N KI mouse model provides a powerful tool for future disease modeling and pharmacological studies of PD. Our data support the involvement of VPS35 in the development of α-synuclein pathology in vivo and revealed the important role of mitochondrial fragmentation/dysfunction in the pathogenesis of VPS35 D620N mutation-associated PD in vivo.
空泡分拣蛋白 35 同源物(VPS35)基因中的 D620N 突变导致晚发性常染色体显性家族性帕金森病(PD),并导致特发性 PD。然而,D620N 突变如何导致体内与 PD 相关的缺陷仍不清楚。在本研究中,我们对慢性衰老的 VPS35 D620N 敲入(KI)小鼠模型的生化、病理和行为变化进行了全面描述。我们报道,该 VPS35 D620N KI 模型在 14 个月龄时重现了 PD 的一系列主要特征,包括与年龄相关的进行性运动缺陷、纹状体中多巴胺(DA)及其代谢物水平的显著变化、以及 SNpc 中的 DA 神经元和纹状体中的 DA 末梢的强烈神经退行性变,伴随着神经炎症的增加,以及 DA 神经元中α-突触核蛋白的积累和聚集。从机制上讲,D620N 突变通过增强 VPS35-DLP1 相互作用和体内线粒体 DLP1 复合物的周转率,导致衰老小鼠中线粒体的碎片化和功能障碍。最后,VPS35 D620N KI 小鼠对 MPTP 介导的黑质纹状体通路变性表现出更大的易感性,表明 VPS35 D620N 突变增加了 DA 神经元对环境毒素的易感性。总的来说,该 VPS35 D620N KI 小鼠模型为未来的 PD 疾病建模和药理学研究提供了有力的工具。我们的数据支持 VPS35 参与体内α-突触核蛋白病理学的发展,并揭示了线粒体碎片化/功能障碍在体内 VPS35 D620N 突变相关 PD 发病机制中的重要作用。